SBHMY (SBHMY) Stock Price & Analysis
SBHMY (SBHMY) fell 13.12% to USD 12.98 as of June 9, 2026 at 23:56 UTC, according to Nexqual real-time market data.
SBHMY last closed at USD 14.94; the session ranged USD 12.98–12.98 on volume of 1 shares. Market capitalization is $11.58B, with a 52-week range of USD 9.48–20.16 (PNK). Source: Nexqual, June 9, 2026 at 23:56 UTC.
Key Statistics (as of June 9, 2026 at 23:56 UTC)
| Price | USD 12.98 |
|---|---|
| Change | ▼ 13.12% (down) |
| Previous Close | USD 14.94 |
| Open | USD 12.98 |
| Day Range | USD 12.98 – 12.98 |
| 52-Week Range | USD 9.48 – 20.16 |
| Volume | 1 shares |
| Market Cap | $11.58B |
| Exchange | PNK |
Technical Analysis (SBHMY)
Nexqual's technical model rates SBHMY "SELL" based on 2 bullish and 5 bearish signals across 124 daily candles, as of June 9, 2026 at 23:56 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 0.98 (oversold) |
| vs SMA50 | Below (USD 14.6) |
| MACD | -0.63 (negative) |
Analyst Ratings (SBHMY)
Wall Street analysts rate SBHMY "None", per Nexqual as of June 9, 2026 at 23:56 UTC.
| Consensus Rating | None |
|---|
Earnings (SBHMY)
Source: Nexqual, June 9, 2026 at 23:56 UTC.
Financials & Fundamentals (SBHMY)
| Total Revenue | $31.83B |
|---|---|
| Revenue Growth (YoY) | +9.80% |
| Gross Margin | +82.07% |
| Operating Margin | +20.22% |
| Profit Margin | +7.36% |
| ROE | +12.53% |
| Debt / Equity | 38.18 |
| Current Ratio | 1.37 |
| Total Cash | $22.96B |
| Total Debt | $16.07B |
| Free Cash Flow | $6.60B |
Source: Nexqual, June 9, 2026 at 23:56 UTC.
Financial Health Score (SBHMY)
Nexqual rates SBHMY's overall financial health "Solid" across five dimensions, as of June 9, 2026 at 23:56 UTC.
| Growth | Solid — Revenue +10% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 82%, operating 20% |
| Balance Sheet | Solid — $23.0B cash vs $16.1B debt, net cash position |
| Cash Flow | Strong — FCF $6.60B, 21% margin |
| Efficiency | Mixed — ROE 13%, ROA 5.6% |
Ownership (SBHMY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 891.82M |
| Float | 438.49M |
Source: Nexqual, June 9, 2026 at 23:56 UTC.
Leadership (SBHMY)
SBHMY is led by S. Y. Tse (age 29), CEO & Executive Director, per Nexqual as of June 9, 2026 at 23:56 UTC.
| CEO & Executive Director | S. Y. Tse (age 29) |
|---|---|
| Founder & Senior Executive Vice Chairman | Ping Tse (age 73) |
| Executive Director | Zhoushan Tian (age 61) |
| Senior VP & Executive Director | Hsin Tse (age 55) |
| Vice President of Public Affairs & ESG | Song Jin (age 49) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| UCBJY | UCB S.A. | USD 151.74 | ▲ 1.47% |
| OTSKY | Otsuka Holdings Co. Ltd. | USD 31.86 | ▼ 2.03% |
| SGIOY | Shionogi & Co. Ltd. | USD 8.56 | ▼ 2.28% |
| WXXWY | Wuxi Biologics (Cayman) Inc | USD 7.6 | ▼ 7.09% |
| OPHLY | Ono Pharmaceutical Co., Ltd. | USD 4.56 | ▲ 0.22% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:56 UTC. This page is informational and not investment advice.